These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 11825326)

  • 1. Pancreatic cancer: the evolving role of systemic therapy.
    Adsay NV; El-Rayes BF; Philip PA
    Expert Opin Pharmacother; 2001 Dec; 2(12):1939-47. PubMed ID: 11825326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Developments in the systemic therapy of pancreatic cancer.
    el-Rayes BF; Shields AF; Vaitkevicius V; Philip PA
    Cancer Invest; 2003; 21(1):73-86. PubMed ID: 12643012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of gemcitabine alone and in combination in the treatment of pancreatic cancer.
    Oettle H; Arnold D; Hempel C; Riess H
    Anticancer Drugs; 2000 Nov; 11(10):771-86. PubMed ID: 11142685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gemcitabine: progress in the treatment of pancreatic cancer.
    Heinemann V
    Oncology; 2001; 60(1):8-18. PubMed ID: 11150902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is there a standard of care for the management of advanced pancreatic cancer?. Highlights from the Gastrointestinal Cancers Symposium. Orlando, FL, USA. January 25-27, 2008.
    Saif MW
    JOP; 2008 Mar; 9(2):91-8. PubMed ID: 18326919
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical update of gemcitabine in pancreas cancer.
    Au E
    Gan To Kagaku Ryoho; 2000 May; 27 Suppl 2():469-73. PubMed ID: 10895197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conventional chemotherapy of advanced pancreatic cancer.
    Giuliani F; Di Maio M; Colucci G; Perrone F
    Curr Drug Targets; 2012 Jun; 13(6):795-801. PubMed ID: 22458526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gemcitabine and platinum combinations in pancreatic cancer.
    Philip PA
    Cancer; 2002 Aug; 95(4 Suppl):908-11. PubMed ID: 12209670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Chemoradiation for pancreatic adenocarcinoma].
    Flandin I; Mornex F; Claude L; Kubas A; Khodri M; Wautot V; Mazeron R; Partensky C
    Cancer Radiother; 2004 Nov; 8 Suppl 1():S80-7. PubMed ID: 15679252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gemcitabine-based combination treatment of pancreatic cancer.
    Heinemann V
    Semin Oncol; 2002 Feb; 29(1 Suppl 3):25-35. PubMed ID: 11894005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gemcitabine following radiotherapy with concurrent 5-fluorouracil for nonmetastatic adenocarcinoma of the pancreas.
    Kachnic LA; Shaw JE; Manning MA; Lauve AD; Neifeld JP
    Int J Cancer; 2001 Apr; 96(2):132-9. PubMed ID: 11291097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systemic treatment of pancreatic cancer.
    Van Cutsem E; Aerts R; Haustermans K; Topal B; Van Steenbergen W; Verslype C
    Eur J Gastroenterol Hepatol; 2004 Mar; 16(3):265-74. PubMed ID: 15195889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of metastatic pancreatic adenocarcinoma: a comprehensive review.
    Kozuch P; Petryk M; Evans A; Bruckner HW
    Surg Clin North Am; 2001 Jun; 81(3):683-90. PubMed ID: 11459281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systemic therapy for advanced pancreatic cancer.
    El-Rayes BF; Philip PA
    Expert Rev Anticancer Ther; 2002 Aug; 2(4):426-36. PubMed ID: 12647986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. What's new in pancreatic cancer treatment?
    Fung MC; Sakata T
    J Hepatobiliary Pancreat Surg; 2002; 9(1):61-75. PubMed ID: 12021899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pancreatic cancer: is this bleak landscape finally changing? Highlights from the '43rd ASCO Annual Meeting'. Chicago, IL, USA. June 1-5, 2007.
    Saif MW
    JOP; 2007 Jul; 8(4):365-73. PubMed ID: 17625289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In response to Li et al.: Concurrent chemoradiotherapy treatment of locally advanced pancreatic cancer: gemcitabine versus 5-fluorouracil, a randomized controlled study. IJROBP 2003;57:98-104.
    Crane CH
    Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):1009; author reply 1009-10. PubMed ID: 14967465
    [No Abstract]   [Full Text] [Related]  

  • 18. Nanoliposomal irinotecan plus fluorouracil and folinic acid as a second-line treatment option in patients with metastatic pancreatic ductal adenocarcinoma: a retrospective cohort study.
    Park SJ; Kim H; Shin K; Hong TH; Suh JH; Lee MA
    BMC Cancer; 2021 Nov; 21(1):1176. PubMed ID: 34732161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Any progress in the management of advanced pancreatic cancer? Highlights from the 45th ASCO annual meeting. Orlando, FL, USA. May 29-June 2, 2009.
    Li J; Saif MW
    JOP; 2009 Jul; 10(4):361-5. PubMed ID: 19581735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Results of gemcitabine hydrochloride in the treatment for pancreatic cancer].
    Tsukagoshi S
    Gan To Kagaku Ryoho; 2001 Oct; 28(10):1461-7. PubMed ID: 11681259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.